Cancer Society (DKG). In addition to the treatment of soft tissue tumors, the center was also recognized for the treatment of bone tumors. The certificate attests that the center works according to current [...] therapy depending on the individual tumor situation," says Professor Dr. Mohamed Omar, medical director of the Sarcoma Center and division head of musculoskeletal tumor surgery at the MHH Department of Trauma [...] with the in-house molecular tumor board. The disease-specific range of treatments is supplemented by aftercare and supportive multiprofessional care services. Bone tumors: special implants using 3D technology

the invaders. Standard immunotherapies against tumors target the acquired immune system, which is weakened by the cancer. This is because although some tumors are teeming with immune cells, they do not attack [...] interested in the influence of fatty liver disease on the immune response in liver tumors and the role of ILCs in the immediate tumor environment. "The therapeutic potential of ILCs for immunotherapy is still [...] defense and how they communicate with cells of the acquired immune system in the HCC tumor. To do this, samples of human tumor tissue are compared with healthy liver tissue and analyzed to determine which immune

to structures that are mainly located on the tumor cell, but not on the patient’s immune cells,” says Professor Schambach. Soften immunosuppression in tumor environment However, the CAR-NK cells have a [...] microenvironment softens the immunosuppressive effect in the area of the solid tumor, which further improves the destruction of the tumor cells,” explains Professor Schambach. If suitable candidates for the immune [...] are part of the first line of defense of our immune system. They eliminate virus-infested cells and tumor cells. This makes NK cells interesting helpers in cancer therapy. Professor Dr. Dr. Axel Schambach

differences were seen in tumor patterns. "Patients who met the LFS genetic testing criteria had a higher incidence of early adrenal, brain, connective tissue and bone tumors, whereas TP53 variant carriers [...] TP53 variants in patients with severe disease compared to those with milder courses. Differences in tumor characteristics Of the 3,034 people, 2,139 (70.5 per cent) met the LFS genetic test criteria or developed [...] risk, their family members’ cancer risk, as well as to more precisely utilize strategies for early tumor detection,” says Malkin of The Hospital for Sick Children, Toronto. “The approach we took lends itself

Improved chances of recovery due to screening Those with lung tumors that are detected at an early stage have a better chance of recovery. The tumors are often still small, localized and have not yet spread [...] subjects are examined using modern and gentle low-dose computer tomography (CT). In this way, lung tumors can be detected at an early stage and the mortality rate from lung cancer reduced. The test is carried

this problem and set up a cooperation network. It provides local care for patients with a genetic tumor risk in Lower Saxony and Saxony."In Germany, around half a million people are diagnosed with cancer [...] their genetic make-up that carries an increased risk of cancer and can lead to the development of tumors," says Professor Dr. Anke Bergmann, specialist in human genetics and head of the OnkoRiskNET project [...] want to ensure access to genetic counseling, diagnostics and risk-adapted prevention for genetic tumor risk syndromes in structurally weak regions." Professor Dr. Brigitte Schlegelberger, Director of the

the Charité in Berlin and site director at the Virchow-Klinikum campus. He is a renowned expert in tumor and transplant surgery with particular expertise in laparoscopic and robotic surgery. Scientifically [...] organs with good results. In addition, we will increasingly offer living donation, especially for tumor patients, and this will be done more and more gently using the surgical robot. What is the importance

risk of various types of cancer. The genetic defect can lead to multiple occurrences of malignant tumors already in childhood. In order to be able to recognize the signs of cancer at an early stage and

aids and tools for early detection, diagnosis and treatment are evaluated, such as the Molecular Tumor Board, which is used for interdisciplinary treatment decisions in particularly severe cancer cases

treats around 700 people with various vascular diseases of the brain, spine or spinal cord as well as tumors of the head and neck. Around 220 of these are patients who have suffered a stroke. The aim is to